Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Total revenue | -15.98M | 20.78M | 14.01M | 47.27%62.21M | 43.76%42.24M | 29.38M |
| Cost of revenue | -12.59M | 15.81M | 8.71M | 50.74%47.14M | 64.81%31.27M | 18.98M |
| Gross profit | -3.4M | 4.97M | 5.31M | 37.38%15.06M | 5.37%10.97M | 10.41M |
| Operating expense | -2.38M | 1.96M | 3.5M | 72.62%3.88M | -38.61%2.25M | 3.67M |
| Staff costs | ---- | ---- | ---- | 34.14%1.5M | -49.75%1.12M | --2.23M |
| Selling and administrative expenses | ---1.88M | --1.67M | --2.98M | 10.17%1.71M | 51.02%1.55M | --1.03M |
| -General and administrative expense | ---1.88M | --1.67M | --2.98M | 10.17%1.71M | 51.02%1.55M | --1.03M |
| Depreciation and amortization | ---- | ---- | ---- | 28.49%478K | 9.41%372K | --340K |
| -Depreciation | ---- | ---- | ---- | 28.49%478K | 9.41%372K | --340K |
| -Amortization | ---- | ---- | ---- | --0 | --0 | --0 |
| Rent and land expenses | ---- | ---- | ---- | 191.67%35K | 300.00%12K | --3K |
| Other operating expenses | ---503K | --294K | --529K | 119.58%158K | -1,322.73%-807K | --66K |
| Operating profit | -1.02M | 3.01M | 1.8M | 28.28%11.18M | 29.28%8.72M | 6.74M |
| Net non-operating interest income (expenses) | 589K | -520K | -561K | -142.05%-639K | -218.07%-264K | -83K |
| Non-operating interest income | ---- | ---- | ---- | 12.36%100K | 36.92%89K | --65K |
| Non-operating interest expense | ---589K | --520K | --561K | 115.81%628K | 146.61%291K | --118K |
| Total other finance cost | ---- | ---- | ---- | 79.03%111K | 106.67%62K | --30K |
| Net investment income | -190.83%-99K | 705.56%109K | -18K | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | 2K | 0 | -6K | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | 129.73%85K | 37K | 0 | |||
| Income from associates and other participating interests | ||||||
| Special income (charges) | 0 | 0 | 0 | -112.92%-89.56K | -71.31%693.19K | 2.42M |
| Less:Write off | --0 | --0 | --0 | 112.92%89.56K | 71.31%-693.19K | ---2.42M |
| Other non-operating income (expenses) | -1.01M | 1.36M | 758K | -32.94%57K | 63.46%85K | 52K |
| Income before tax | -1.44M | 3.84M | 2M | 11.95%10.5M | 2.99%9.37M | 9.1M |
| Income tax | -668K | 1.1M | 960K | 28.25%2.77M | -7.59%2.16M | 2.34M |
| Net income | -770K | 2.75M | 1.04M | 7.07%7.72M | 6.65%7.21M | 6.76M |
| Net income continuous operations | ---770K | --2.75M | --1.04M | 7.07%7.72M | 6.65%7.21M | --6.76M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | -770K | 2.75M | 1.04M | 7.07%7.72M | 6.65%7.21M | 6.76M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -770K | 2.75M | 1.04M | 7.07%7.72M | 6.65%7.21M | 6.76M |
| Gross dividend payment | ||||||
| Basic earnings per share | -0.002 | 0.005 | 0.002 | 7.07%0.0154 | 6.65%0.0144 | 0.0135 |
| Diluted earnings per share | -0.002 | 0.005 | 0.002 | 7.07%0.0154 | 6.65%0.0144 | 0.0135 |
| Dividend per share | ||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.